Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2025-12-25 @ 4:05 AM
NCT ID:
NCT07185802
Eligibility Criteria:
Inclusion criteria:
* Patients of both sexes who are older than 18 years and younger than 50 years
* 3 or Less than 3-months history of knee injuries
* ACL injury MRI Grade 1 (Low) and medium Grade 2 (Medium) grade
* ACL injury associated with Grade 1 or 2 Posterior cruciate ligament (PCL) tear and/or Grade 1 or 2 meniscal tear
* The Complete Blood Count (CBC) report shows a hemoglobin \> 10gm/dl and platelet count \>150,000/microliter prior to the procedure
* Capable of comprehending informed consent
Exclusion criteria:
* Patients who have had intra articular corticosteroid injections in the index knee during the last 12 weeks
* Patients who are taking systemic steroid
* Patients who are younger than 18 and older than 50 years
* Those with a history of platelet disorders or on the therapeutic anticoagulant or anti platelet drugs
* Hemoglobin below 10 gm/dl
* Platelet count \<150000/microliter
* Complete tear of both bundles on MRI
* Grade 3 or more PCL and meniscal tear on MRI
* Previous or concurrent ligament reconstruction in the index knee joint.
* Connective tissue disorders like Marfan Syndrome, Ehler-Danlos Syndrome etc.
* Any inflammatory disease like Rheumatoid Arthritis, spondyloarthritis, gout, pseudogout etc involving the knee joint.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT07185802
Study Brief:
Protocol Section:
NCT07185802